• Stem Cells
• 34 min
  1. Stem cells: immortality or a healthy old age?

  • Dr. Jim McWhir
• 40 min
  2. Mouse embryonic stem cells

  • Prof. Sir Martin Evans
• Regenerative Medicine (I)
• 26 min
  3. Stem cells and regenerative medicine

  • Prof. Dame Julia Polak
  • Dr. Anne Bishop
• 27 min
  4. Tissue engineering: the science, the technology and the industry

  • Prof. Robert Nerem
• 41 min
  5. Clinical potential of stem cells

  • Prof. John Martin
• 11 min
  6. Genes and cells therapy

  • Prof. Nagy Habib
• Regenerative Medicine (II)
• 39 min
  7. Stem cell therapy for the treatment of heart failure

  • Dr. James Willerson
• 35 min
  8. Vascular tissue engineering

  • Prof. Robert Nerem
• 43 min
  9. Stem cell biology and neurodegenerative diseases

  • Dr. Ronald McKay
• 17 min
  10. Cartilage stem cells: tools for joint repair?

  • Prof. Charles Archer
• Biotechnology
• 46 min
  11. Stem cell bioprocessing

  • Dr. Sakis Mantalaris
• 68 min
  12. Nanotechnology for tissue engineering

  • Prof. Thomas J. Webster
• 37 min
  13. Materials for tissue engineering

  • Dr. Molly Stevens
  • Mr. Julian George
• Commercialization
• 36 min
  14. Commercialisation of stem cells

  • Dr. Gareth Roberts
• Ethical and Regulatory Considerations
• 44 min
  15. Stem cell ethics

  • Prof. Dame Anne McLaren
• 23 min
  16. The human fertilisation and embryology authority

  • Dame Suzi Leather
• Archived Lectures *These may not cover the latest advances in the field
• 40 min
  17. Bioethics & politics of human embryonic stem cell science in the EU's 6th framework programme

  • Prof. Brian Salter

Printable Handouts

PDF

Navigable Slide Index

1. Introduction
2. Why use cells in regenerative medicine?
3. Regenerative medicine/tissue engineering
4. Why use cells at all?
5. Cell issues - intellectual property
6. Human ES cells - the choice?
7. Ethics (1)
8. Ethics (2)
9. Cell issues- source of cells
10. Bone marrow transplant
11. Cord blood
12. Stem cell technology problems
13. Smart bioreactors
14. Chondrogenic differentiation from ES cells
15. TheraMachine - working prototype
16. Bioprocessing system
17. HARV - micro-CT
18. Differentiation of stem cells
19. hESC encapsulation
20. Lung epithelium differentiation
21. Strategy (1)
22. Best cell to commercialize
23. Stem cell products
24. Lung disease in the EEC and UK
25. Lung disease in the USA
26. Vision: lung
27. Strategy (2)
28. Novalung - interventional lung assist
29. Lung assist device
30. Cannulation of A./V. femoralis
31. BioHybrid toxicology
32. Human therapeutics
33. Managing expectations
34. We have been here before
35. Investors
36. Commercial stem cell technology
37. Commercial cell products
38. The best cells for commercial applications
39. The best stem cells for commercial applications
40. End of presentation

Topics Covered

• Why use stem cells?
• The IP problems of commercializing stem cell research
• Ethics and commercialization
• Selecting stem cells for commercial development
• Producing cells for product development
• Scale-up and quality issues
• The promise of automation
• Developing a product
• Lung disease: the medical need and the approach
• Simplifying the strategy by simplifying the product
• R&D of a lung assist device for lung therapeutics
• The key lesson for commercial development

Links

Series:

• Stem Cells and Regenerative Medicine

Categories:

• Cell Biology
• Methods

Talk Citation

Publication History

• Published on October 1, 2007

Financial Disclosures

• Dr. Gareth Roberts has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.